NO961747L - Behandling av reumatoid artritt - Google Patents

Behandling av reumatoid artritt

Info

Publication number
NO961747L
NO961747L NO961747A NO961747A NO961747L NO 961747 L NO961747 L NO 961747L NO 961747 A NO961747 A NO 961747A NO 961747 A NO961747 A NO 961747A NO 961747 L NO961747 L NO 961747L
Authority
NO
Norway
Prior art keywords
rheumatoid arthritis
treatment
inflammatory
arthritis
chronic
Prior art date
Application number
NO961747A
Other languages
English (en)
Norwegian (no)
Other versions
NO961747D0 (no
Inventor
Irwin A Braude
Original Assignee
Neurobiological Technologies I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurobiological Technologies I filed Critical Neurobiological Technologies I
Publication of NO961747D0 publication Critical patent/NO961747D0/no
Publication of NO961747L publication Critical patent/NO961747L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2228—Corticotropin releasing factor [CRF] (Urotensin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO961747A 1993-11-02 1996-04-30 Behandling av reumatoid artritt NO961747L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14652093A 1993-11-02 1993-11-02
PCT/US1994/012621 WO1995012416A1 (en) 1993-11-02 1994-11-02 Treatment for rheumatoid arthritis

Publications (2)

Publication Number Publication Date
NO961747D0 NO961747D0 (no) 1996-04-30
NO961747L true NO961747L (no) 1996-07-02

Family

ID=22517765

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961747A NO961747L (no) 1993-11-02 1996-04-30 Behandling av reumatoid artritt

Country Status (10)

Country Link
EP (1) EP0726780A1 (lt)
JP (1) JPH09504792A (lt)
AU (1) AU8131694A (lt)
CA (1) CA2175457A1 (lt)
CZ (1) CZ122696A3 (lt)
HU (1) HUT74275A (lt)
LT (1) LT96079A (lt)
NO (1) NO961747L (lt)
PL (1) PL314191A1 (lt)
WO (1) WO1995012416A1 (lt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6060288A (en) * 1994-08-03 2000-05-09 Mosaic Technologies Method for performing amplification of nucleic acid on supports
US5780431A (en) * 1996-09-20 1998-07-14 Neurobiological Technologies, Inc. Pharmaceutical formulations of corticotropin releasing factor having improved stability in liquid form
EP0972081B1 (en) 1997-04-01 2007-06-13 Solexa Ltd. Method of nucleic acid amplification
AR031640A1 (es) 2000-12-08 2003-09-24 Applied Research Systems Amplificacion isotermica de acidos nucleicos en un soporte solido
GEP20115290B (en) * 2002-11-27 2011-09-26 Incyte Corp 3-aminopyrrolidine derivatives as modulators of chemokine receptors
WO2008093098A2 (en) 2007-02-02 2008-08-07 Illumina Cambridge Limited Methods for indexing samples and sequencing multiple nucleotide templates
WO2010038042A1 (en) 2008-10-02 2010-04-08 Illumina Cambridge Ltd. Nucleic acid sample enrichment for sequencing applications
US8182994B2 (en) 2009-09-15 2012-05-22 Illumina Cambridge Limited Centroid markers for image analysis of high denisty clusters in complex polynucleotide sequencing
DE102011100783A1 (de) 2011-05-06 2012-11-08 Rolls-Royce Deutschland Ltd & Co Kg Gasturbinenauswuchtvorrichtung
CN115137809A (zh) * 2021-03-31 2022-10-04 张菁 含有促肾上腺皮质激素及其衍生物的药物及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006330A (en) * 1988-11-30 1991-04-09 The United States Of America As Represented By The Of The Department Of Health And Human Services Evaluative means for detecting inflammatory reactivity

Also Published As

Publication number Publication date
CZ122696A3 (en) 1996-12-11
CA2175457A1 (en) 1995-05-11
EP0726780A1 (en) 1996-08-21
NO961747D0 (no) 1996-04-30
PL314191A1 (en) 1996-09-02
JPH09504792A (ja) 1997-05-13
WO1995012416A1 (en) 1995-05-11
LT96079A (en) 1996-10-25
AU8131694A (en) 1995-05-23
HU9601149D0 (en) 1996-06-28
HUT74275A (en) 1996-11-28

Similar Documents

Publication Publication Date Title
NO961747L (no) Behandling av reumatoid artritt
NO20051987L (no) Behandling av soppinfeksjoner.
TR200002207T1 (tr) Slekoksib bileşikleri.
ATE252382T1 (de) Flurbiprofenhaltige arzneimittel
EP1129718A3 (en) Therapeutic uses of bactericidal/permeability increasing protein products
IS2216B (is) Meðferðaráform við inngjöf á H+,K+ -ATPasa-hemla
FI862916A7 (fi) Matalapaineinen elohopeahöyrypurkauslamppu.
NO923859L (no) Medikament
DE69731610D1 (de) Orale verabreichung wirksamer mengen von hyaluronsäure
DK1037648T3 (da) Anvendelse af erythropoietin og jernpræparater til fremstilling af farmaceutiske kombinationspræparater til behandling af rheumatiske lidelser
EA200400548A1 (ru) Лечение тяжёлой пневмонии путём введения ингибитора пути тканевого фактора (tfpi)
HUP9901360A2 (hu) Cimicifuga racemosa-ból származó extraktum alkalmazása
ES2172695T3 (es) Carboxamidas y sulfonamidas de benzofurano.
DE69733089D1 (de) Behandlung der osteoarthritis durch verabreichung von poly-n-acetyl-d-glucosamin
TR200400228T4 (tr) Psöryazinin tedavisinde kullanılacak maddeler
DK0869965T3 (da) Steroidnitritesterderivater anvendelige som antiinflammatoriske lægemidler
PT782441E (pt) Controlo farmaceutico da inflamacao
NO982874L (no) Farmasöytiske preparater med vitamin D-analoger
FI953565A7 (fi) Uusi antikoagulanttikofaktoriaktiivisuus
NO943288L (no) Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer
NO962450L (no) Forblanding for å fremme vekst hos fisk, samt anvendelse av blandingen
IT1254521B (it) Derivati della 2-ammino-tetralina attivi sul sistema cardiovascolare
DE60031439D1 (de) Verwendung von carboxy verbindungen wie 2(4-acetoxyphenyl)-2-chloro-n-methyl-ethylammonium chlorid als entzündungshemmende mittel
JPS6425717A (en) Method and apparatus for preventing organic nitric acid ester resistance
DK113789A (da) Thiosulfinsyrederivater, deres anvendelse til behandling af betaendelsessygdomme samt laegemiddel indeholdende disse stoffer